Tourmaline Bio Statistics Share Statistics Tourmaline Bio has 25.69M
shares outstanding. The number of shares has increased by 0.18%
in one year.
Shares Outstanding 25.69M Shares Change (YoY) 0.18% Shares Change (QoQ) 0.01% Owned by Institutions (%) 90.33% Shares Floating 16.64M Failed to Deliver (FTD) Shares 50,000 FTD / Avg. Volume 23.37%
Short Selling Information The latest short interest is 2.5M, so 9.75% of the outstanding
shares have been sold short.
Short Interest 2.5M Short % of Shares Out 9.75% Short % of Float 10.91% Short Ratio (days to cover) 15.06
Valuation Ratios The PE ratio is -7.02 and the forward
PE ratio is -7.54.
Tourmaline Bio's PEG ratio is
0.1.
PE Ratio -7.02 Forward PE -7.54 PS Ratio 0 Forward PS 183.6 PB Ratio 1.71 P/FCF Ratio -6.65 PEG Ratio 0.1
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Tourmaline Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 30.18,
with a Debt / Equity ratio of 0.
Current Ratio 30.18 Quick Ratio 30.18 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-989.32K Employee Count 74 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 169.92% in the
last 52 weeks. The beta is 2.06, so Tourmaline Bio's
price volatility has been higher than the market average.
Beta 2.06 52-Week Price Change 169.92% 50-Day Moving Average 21.5 200-Day Moving Average 18.46 Relative Strength Index (RSI) 94.53 Average Volume (20 Days) 213,916
Income Statement
Revenue n/a Gross Profit -39K Operating Income -89.73M Net Income -73.21M EBITDA -89.73M EBIT -73.21M Earnings Per Share (EPS) -2.89
Full Income Statement Balance Sheet The company has 30.51M in cash and 244K in
debt, giving a net cash position of 30.26M.
Cash & Cash Equivalents 30.51M Total Debt 244K Net Cash 30.26M Retained Earnings -135.26M Total Assets 269.3M Working Capital 239.01M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -77.26M
and capital expenditures -9K, giving a free cash flow of -77.27M.
Operating Cash Flow -77.26M Capital Expenditures -9K Free Cash Flow -77.27M FCF Per Share -3.05
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields TRML does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for TRML is $49,
which is 2.9% higher than the current price. The consensus rating is "Buy".
Price Target $49 Price Target Difference 2.9% Analyst Consensus Buy Analyst Count 8
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 20, 2023. It was a
backward
split with a ratio of 1:10.
Last Split Date Oct 20, 2023 Split Type backward Split Ratio 1:10
Scores Altman Z-Score 32.69 Piotroski F-Score 1
